Tower Research Capital (TRC)’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-135
Closed -$170 5260
2025
Q1
$170 Buy
+135
New +$170 ﹤0.01% 4997
2024
Q4
Sell
-1,557
Closed -$5.37K 5694
2024
Q3
$5.37K Sell
1,557
-4,215
-73% -$14.5K ﹤0.01% 4286
2024
Q2
$29.4K Buy
5,772
+5,038
+686% +$25.6K ﹤0.01% 3502
2024
Q1
$6.22K Sell
734
-482
-40% -$4.08K ﹤0.01% 4407
2023
Q4
$4.98K Sell
1,216
-1,386
-53% -$5.67K ﹤0.01% 4892
2023
Q3
$7.81K Buy
2,602
+2,144
+468% +$6.43K ﹤0.01% 4432
2023
Q2
$14.2K Sell
458
-133
-23% -$4.11K ﹤0.01% 3695
2023
Q1
$29K Buy
591
+521
+744% +$25.6K ﹤0.01% 3018
2022
Q4
$2K Buy
+70
New +$2K ﹤0.01% 5329
2022
Q3
Sell
-370
Closed -$15K 6057
2022
Q2
$15K Buy
+370
New +$15K ﹤0.01% 4055
2022
Q1
Sell
-229
Closed -$14K 6085
2021
Q4
$14K Buy
+229
New +$14K ﹤0.01% 4054
2021
Q2
Sell
-787
Closed -$45K 5465
2021
Q1
$45K Buy
787
+498
+172% +$28.5K ﹤0.01% 3209
2020
Q4
$20K Sell
289
-1,286
-82% -$89K ﹤0.01% 3867
2020
Q3
$400K Buy
1,575
+1,487
+1,690% +$378K ﹤0.01% 1931
2020
Q2
$15K Sell
88
-691
-89% -$118K ﹤0.01% 3808
2020
Q1
$54K Buy
779
+35
+5% +$2.43K ﹤0.01% 1255
2019
Q4
$48K Buy
744
+701
+1,630% +$45.2K ﹤0.01% 1359
2019
Q3
$2K Buy
+43
New +$2K ﹤0.01% 3655
2018
Q4
Sell
-46
Closed -$3K 3820
2018
Q3
$3K Sell
46
-46
-50% -$3K ﹤0.01% 3277
2018
Q2
$5K Buy
92
+11
+14% +$598 ﹤0.01% 3050
2018
Q1
$4K Sell
81
-19
-19% -$938 ﹤0.01% 2771
2017
Q4
$6K Sell
100
-19
-16% -$1.14K ﹤0.01% 2796
2017
Q3
$7K Buy
+119
New +$7K ﹤0.01% 3193
2016
Q4
Hold
0
3816
2016
Q3
Hold
0
3636
2016
Q2
Sell
-67
Closed -$3K 4420
2016
Q1
$3K Buy
67
+51
+319% +$2.28K ﹤0.01% 3048
2015
Q4
$1K Sell
16
-65
-80% -$4.06K ﹤0.01% 4022
2015
Q3
$3K Buy
81
+49
+153% +$1.82K ﹤0.01% 3097
2015
Q2
$2K Buy
32
+24
+300% +$1.5K ﹤0.01% 3691
2015
Q1
$1K Buy
+8
New +$1K ﹤0.01% 4020
2014
Q4
Hold
0
4020